Averica Discovery Services Inc., an analytical development contract research organization, and Dalton Pharma Services, a contract development and manufacturing organization, have formed a preferred provider agreement involving advanced analytical services.

Averica provides expertise in impurity isolation, small-molecule analysis, and purification. Dalton provides active pharmaceutical ingredient development and cGMP manufacturing. Averica's capabilities will expand Dalton's capacity and allow faster validation of assay, impurities, and release testing methods. The expertise of Averica in impurity isolation can also improve timelines for Dalton's clinical and commercial cGMP synthesis.

Source: Dalton Pharma Services